FGFR1 and pulmonary fibrosis: Therefore, we reasoned that miR‐503 negatively regulated the TGF‐β1‐induced effects in fibroblast by co‐targeting VEGFA and FGFR1 to affect the MAPK/ERK pathway, thus alleviating silica‐induced pulmonary fibrosis.